From: Design, synthesis, anticancer evaluation and docking studies of novel 2-(1-isonicotinoyl-3-phenyl-1H-pyrazol-4-yl)-3-phenylthiazolidin-4-one derivatives as Aurora-A kinase inhibitors
Comp
R
R1
Affinity (kcal/mol)
Log p
HBD
HBA
PSA
MR
P-6
NO2
4-OCH3
− 16.7
2.71
0
7
118.24
133.33
P-20
Br
− 14.8
3.55
5
75.10
134.64
VX-680
− 25.6
4..87
3
49.46
136.36